Dual-currency biomedical venture firm Lily Asia Ventures (LAV) has closed its seventh USD fund, roping in sovereigns, pensions, endowments, foundations, family offices and funds of funds.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
